Also, those individuals with known sensitivities to lidocaine, atropine, or benzodiazepines should not use the device. Alair is not studied for success in retreatment of the same section of the lung. Presently, patients shouldn’t be retreated with the Alair system in the same area of the lung. Asthma patients taking into consideration the Alair system should not be treated while the following conditions are present: an active respiratory illness, coagulopathy , asthma exacerbations, or if indeed they have had changes to their corticosteroid regimen 2 weeks prior to the proposed treatment.. Alair Bronchial Thermoplasty Program receives FDA approval to take care of asthma in adults FDA Approves New Device for Adults with Severe and Persistent Asthma The U.S.Patients At 22 centers in Canada , the United States , South Korea , Ireland , and the uk , a complete of 316 participants underwent randomization before the trial was stopped: 165 individuals were assigned to the intervention group, 150 participants were assigned to the control group, and 1 participant was excluded due to improper consent methods. The trial enrolled 1.from February 2013 through October 2014 44 participants per center per month.